Evaluation of the detection of Mycobacterium tuberculosis with metabolic activity in culture-negative human clinical samples

Clinical Microbiology and Infection

Volumn 19, Issue 3, 2013, Pages 273-278

  Cubero, N ^a,b   Esteban, J ^c   Palenque, E ^d   Rosell, A ^b   Garcia, M J ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UAM)   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Latent tuberculosis; Quantitative polymerase chain reaction; Ribosomal operon rrn PCL1 promoter; Tuberculosis; Viable but non cultivable bacilli

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BIOLOGICAL ACTIVITY; CLINICAL EVALUATION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES CULTIVATION;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

EID: 84874303442     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2012.03779.x     Document Type: Article

References (31)

1. WHO. Global tuberculosis control: epidemiology, strategy, finances: WHO report ISBN 978 92 4 156380 2 2009.
2. Goodman A, Lipman M. Tuberculosis. Clin Med 2008; 8: 531-534.
3. Hopewell PC. Overview of clinical tuberculosis. In: Bloom BR, ed. Tuberculosis pathogenesis, protection and control. Washington, D.C.: American Society for Microbiology, 1994; 25-46.
4. Mack U, Migliori GB, Sester M et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A tbnet consensus statement. Eur Respir J 2009; 33: 956-973.
5. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33years of latent infection. J Infect Dis 2002; 185: 401-404.
6. Rieder H. Epidemiologic basis of tuberculosis control. Paris: International Union Against Tuberculosis and Lung Disease, 1999.
7. Styblo K. Epidemiology of tuberculosis. The Hague: KNCV Tuberculosis Foundation, 1991.
8. Dworkin J, Shah IM. Exit from dormancy in microbial organisms. Nat Rev Microbiol 2010; 8: 890-896.
9. Hernandez-Pando R, Jeyanathan M, Mengistu G et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000; 356: 2133-2138.
10. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence?PLoS ONE 2006; 1: e43.
11. Cardona PJ. A dynamic reinfection hypothesis of latent tuberculosis infection. Infection 2009; 37: 80-86.
12. Barry CE 3rd, Boshoff HI, Dartois V et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009; 7: 845-855.
13. Menzies R, Vissandjee B. Effect of bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-625.
14. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007; 131: 1898-1906.
15. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4: 761-776.
16. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006; 61: 783-790.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
18. Bauer HM, Ting Y, Greer CE et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265: 472-477.
19. Eisenach KD, Cave MD, Bates JH, Crawford JT. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis 1990; 161: 977-981.
20. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16: 319-354.
21. Menendez Mdel C, Rebollo MJ, Nunez Mdel C, Cox RA, Garcia MJ. Analysis of the precursor rrnA fractions of rapidly growing mycobacteria: quantification by methods that include the use of a promoter (rrnA p1) as a novel standard. J Bacteriol 2005; 187: 534-543.
22. Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev 2003; 16: 463-496.
23. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15: 716-746.
24. Falkinham JO 3rd. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol 2009; 107: 356-367.
25. de Wit D, Wootton M, Dhillon J, Mitchison DA. The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuberc Lung Dis 1995; 76: 555-562.
26. Hellyer TJ, DesJardin LE, Teixeira L, Perkins MD, Cave MD, Eisenach KD. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA. J Clin Microbiol 1999; 37: 518-523.
27. Jou NT, Yoshimori RB, Mason GR, Louie JS, Liebling MR. Single-tube, nested, reverse transcriptase PCR for detection of viable Mycobacterium tuberculosis. J Clin Microbiol 1997; 35: 1161-1165.
28. Garcia MJ, Nunez MC, Cox RA. Measurement of the rates of synthesis of three components of ribosomes of Mycobacterium fortuitum: a theoretical approach to qRT-PCR experimentation. PLoS ONE 2010; 5: e11575.
29. Shanmugam S, Selvakumar N, Narayanan S. Drug resistance among different genotypes of Mycobacterium tuberculosis isolated from patients from Tiruvallur, South India. Infect Genet Evol 2011; 11: 980-986.
30. Cosma CL, Sherman DR, Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 2003; 57: 641-676.
31. Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat Med 2000; 6: 1327-1329.